In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. 2005
alf:
Targeting Acute Allograft Rejection by Immunotherapy With Ex Vivo-Expanded Natural CD4+CD25+ Regulatory T Cells. 2006
alf:
Ex vivo activated OVA specific and non-specific CD4(+)CD25(+) regulatory T cells exhibit comparable suppression to OVA mediated T cell responses. 2006
alf:
Competition controls the rate of transition between the peripheral pools of CD4+CD25- and CD4+CD25+ T cells. 2006
alf:
Signaling through 4-1bb receptor reversibly inhibits the suppressive function of cd4+cd25+foxp3+ T regulatory cells. 2006
alf:
Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors. 2006
alf:
Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T cell lines upon in vitro expansion. 2006
alf:
Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. 2006
alf:
Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. 2006
alf:
Comment on "Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells". 2006
alf: